Teva Pharmaceutical Industries Limited (BVMF:T1EV34)

Market Cap	156.94B
Revenue (ttm)	89.41B
Net Income (ttm)	3.80B
Shares Out	n/a
EPS (ttm)	3.29
PE Ratio	41.30
Forward PE	9.72
Dividend	n/a
Ex-Dividend Date	n/a

Volume	296
Average Volume	26
Open	67.41
Previous Close	n/a
Day's Range	67.41 - 67.62
52-Week Range	39.30 - 70.28
Beta	0.70
RSI	75.22
Earnings Date	Nov 5, 2025

About BVMF:T1EV34

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1901
• Employees: 35,686
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: T1EV34

Financial Performance

In 2024, BVMF:T1EV34's revenue was $16.54 billion, an increase of 4.40% compared to the previous year's $15.85 billion. Losses were -$1.64 billion, 193.2% more than in 2023.

Financial numbers in USD